Recently, regulation of the interleukin (IL)‐33/IL‐37 axis by aryl hydrocarbon receptors (AhR), a receptor for dioxins, has been applied in the treatment of atopic dermatitis and psoriasis.6, 7 The research conducted by Akahoshi et al. The gene discussed is AHR; the disease is atopic eczema.